Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.12% |
| 2 | Healthcare | 2.55% |
| 3 | Financials | 2.39% |
| 4 | Consumer Discretionary | 2.14% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Five Below
FIVE
$13.5B
| $20.6M | ﹤0.01% |
149,503
-91,723
| -38% | -$12M |
|
1802
CALL
Zimmer Biomet
ZBH
$19.2B
| $20.5M | ﹤0.01% |
196,500
+67,500
| +52% | +$7.41M |
|
1803
PUT
Alpha Metallurgical Resources
AMR
$2.11B
| $20.5M | ﹤0.01% |
149,900
+74,600
| +99% | +$10.4M |
|
1804
ChargePoint
CHPT
$160M
| $20.5M | ﹤0.01% |
+69,481
| New | +$21.1M |
|
1805
GlobalFoundries
GFS
$30B
| $20.4M | ﹤0.01% |
422,259
-2,250,740
| -84% | -$121M |
|
1806
CALL
Monster Beverage
MNST
$91.7B
| $20.4M | ﹤0.01% |
938,800
-42,800
| -4% | -$986K |
|
|
Y
1807
DELISTED
Alleghany Corp
Y
| $20.4M | ﹤0.01% |
24,307
+23,897
| +5,829% | +$20M |
|
1808
Teva Pharmaceuticals
TEVA
$42.8B
| $20.4M | ﹤0.01% |
2,526,757
-7,119,914
| -74% | -$63M |
|
|
RXRA
1809
DELISTED
RXR Acquisition Corp. Class A Common Stock
RXRA
| $20.4M | ﹤0.01% |
2,071,848
+318
| +0% | +$3.13K |
|
1810
PUT
Vale
VALE
$58B
| $20.4M | ﹤0.01% |
1,530,300
+683,900
| +81% | +$9M |
|
1811
State Street Health Care Select Sector SPDR ETF
XLV
$43.8B
| $20.4M | ﹤0.01% |
168,026
+73,349
| +77% | +$9.45M |
|
1812
PUT
Revolve Group
RVLV
$1.68B
| $20.3M | ﹤0.01% |
937,700
+8,600
| +0.9% | +$226K |
|
1813
CALL
Steel Dynamics
STLD
$36.7B
| $20.3M | ﹤0.01% |
286,600
+19,300
| +7% | +$1.46M |
|
|
STOR
1814
DELISTED
STORE Capital Corporation
STOR
| $20.3M | ﹤0.01% |
648,455
+487,893
| +304% | +$13.9M |
|
|
1815
CALL
Teva Pharmaceuticals
TEVA
$42.8B
| $20.3M | ﹤0.01% |
2,510,800
-2,703,800
| -52% | -$23.9M |
|
1816
Under Armour
UAA
$2.3B
| $20.2M | ﹤0.01% |
3,043,085
+2,318,523
| +320% | +$20.3M |
|
1817
PUT
BioMarin Pharmaceuticals
BMRN
$13B
| $20.2M | ﹤0.01% |
238,700
-18,800
| -7% | -$1.67M |
|
1818
Xometry
XMTR
$5.52B
| $20.2M | ﹤0.01% |
355,691
+220,979
| +164% | +$10.3M |
|
|
CNR
1819
Core Natural Resources Inc
CNR
$4.76B
| $20.2M | ﹤0.01% |
313,661
-100,488
| -24% | -$6.36M |
|
1820
Pan American Silver
PAAS
$20B
| $20.2M | ﹤0.01% |
1,270,133
+554,465
| +77% | +$9.66M |
|
1821
Columbia Banking Systems
COLB
$9.25B
| $20.1M | ﹤0.01% |
696,417
+96,426
| +16% | +$2.91M |
|
1822
PUT
M&T Bank
MTB
$36.7B
| $20.1M | ﹤0.01% |
113,900
-700
| -0.6% | -$124K |
|
|
BPMC
1823
DELISTED
Blueprint Medicines
BPMC
| $20.1M | ﹤0.01% |
304,787
+235,528
| +340% | +$15.1M |
|
|
SJIV
1824
DELISTED
South Jersey Industries, Inc. Corporate Units
SJIV
| $20.1M | ﹤0.01% |
300,827
+235
| +0.1% | +$16K |
|
1825
PUT
BHP
BHP
$220B
| $20.1M | ﹤0.01% |
401,300
-166,300
| -29% | -$8.81M |
|
Similar funds
Ken Griffin's Q3 2022 Portfolio in Review
As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.
- Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
- Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
- Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.